---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-023293"
form_type: "8-K"
ticker: "STEX"
cik: "0001530766"
company_name: "Streamex Corp."
filed_at: "2024-06-10T23:59:59+00:00"
generated_at: "2026-06-01T05:17:20.924965+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# BioSig Technologies appoints Ferdinand Groenewald as interim CFO after Hrkac resignation

## Summary
- Frederick Hrkac resigned as acting CFO and principal accounting officer effective June 5, 2024.
- Ferdinand Groenewald appointed interim CFO, principal accounting officer, VP finance under consulting agreement.
- Groenewald compensation: $15,000 per month plus expense reimbursement; currently VP Finance at Alaunos Therapeutics.
- Groenewald previously served as CFO of Muscle Maker, Inc. and director of HeartCore and SYLA Technologies.

## SEC filing metadata
- accession: 0001493152-24-023293
- form_type: 8-K
- ticker: STEX
- cik: 0001530766
- company_name: Streamex Corp.
- filed_at: 2024-06-10T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1530766/000149315224023293/0001493152-24-023293-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1530766/000149315224023293/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-023293
- JSON: https://secwatch.observer/filing/0001493152-24-023293.json
- Plain text: https://secwatch.observer/filing/0001493152-24-023293.txt

## Key facts
- Executive change
  Frederick D. Hrkac resigned as acting chief financial officer and principal accounting officer at Streamex Corp..
  - Action: resigned
  - Role: acting chief financial officer and principal accounting officer
  source text: On June 5, 2024, Mr. Frederick D. Hrkac resigned as acting chief financial officer and principal accounting officer of BioSig Technologies, Inc. (“BioSig” or “Company”) effective as of the same date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1530766/000149315224023293/0001493152-24-023293-index.htm
- Executive change
  Ferdinand Groenewald was appointed as interim chief financial officer, principal accounting officer and vice president of finance at Streamex Corp..
  - Action: appointed
  - Role: interim chief financial officer, principal accounting officer and vice president of finance
  source text: Mr. Groenewald will serve as the Company’s interim chief financial officer, principal accounting officer and vice president of finance.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1530766/000149315224023293/0001493152-24-023293-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.